Peter Olaf Hofgaard

Bilde av Peter Olaf Hofgaard
English version of this page
Brukernavn
Besøksadresse Sognsvannsveien 20 Rikshospitalet 0372 Oslo
Postadresse Postboks 4950 Nydalen OUS HF Rikshospitalet 0424 Oslo

Publikasjoner

  • Wang, Dong; Fløisand, Yngvar; Myklebust, Camilla Victoria; Bürgler, Simone; Ribes, Anna Maria Parente & Hofgaard, Peter Olaf [Vis alle 13 forfattere av denne artikkelen] (2017). Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice. Leukemia. ISSN 0887-6924. 31(10), s. 2114–2121. doi: 10.1038/leu.2017.69. Fulltekst i vitenarkiv
  • Kikuchi, Jiro; Koyama, Daisuke; Wada, Taeko; Izumi, Tohru; Hofgaard, Peter Olaf & Bogen, Bjarne [Vis alle 7 forfattere av denne artikkelen] (2015). Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma. Journal of Clinical Investigation. ISSN 0021-9738. 125(12), s. 4375–4390. doi: 10.1172/JCI80325.
  • Haabeth, Ole Audun; Tveita, Anders; Fauskanger, Marte Hotvedt; Schjesvold, Fredrik Hellem; Lorvik, Kristina Berg & Hofgaard, Peter Olaf [Vis alle 11 forfattere av denne artikkelen] (2014). How do CD4+ T cells detect and eliminate tumor cells that either lack or express MHC class II molecules? Frontiers in Immunology. ISSN 1664-3224. 5:174. doi: 10.3389/fimmu.2014.00174. Fulltekst i vitenarkiv
  • Hofgaard, Peter Olaf; Jodal, Henriette Cecilie; Bommert, Kurt; Huard, Bertrand; Caers, Jo & Carlsen, Harald [Vis alle 11 forfattere av denne artikkelen] (2012). A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease. PLOS ONE. ISSN 1932-6203. 7(12). doi: 10.1371/journal.pone.0051892.
  • Follin-Arbelet, Virginie; Hofgaard, Peter Olaf; Hauglin, Harald; Naderi, Soheil; Sundan, Anders & Blomhoff, Rune [Vis alle 8 forfattere av denne artikkelen] (2011). Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model. BMC Cancer. ISSN 1471-2407. 11. doi: 10.1186/1471-2407-11-301. Fulltekst i vitenarkiv
  • Corthay, Alexandre; Lundin, Katrin; Lorvik, Kristina Berg; Hofgaard, Peter Olaf & Bogen, Bjarne (2009). Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4(+) T Cells. Cancer Research. ISSN 0008-5472. 69(14), s. 5901–5907. doi: 10.1158/0008-5472.CAN-08-4816.
  • Heier, Ingvild; Hofgaard, Peter Olaf; Brandtzæg, Per; Jahnsen, Frode Lars & Karlsson, Malin (2008). Depletion of CD4(+) CD25(+) regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma. Clinical and Experimental Immunology. ISSN 0009-9104. 152. doi: 10.1111/j.1365-2249.2008.03642.x.
  • Corthay, Alexandre; Skovseth, Dag Kristian; Lundin, Katrin; Røsjø, Egil; Omholt, Hilde & Hofgaard, Peter Olaf [Vis alle 8 forfattere av denne artikkelen] (2005). Primary antitumor immune response mediated by CD4+ T cells. Immunity. ISSN 1074-7613. 22, s. 371–383.
  • Lundin, Katrin; Screpanti, V; Omholt, Hilde; Hofgaard, Peter Olaf; Yagita, H & Grandien, A. [Vis alle 7 forfattere av denne artikkelen] (2004). CD4(+) T cells kill Id(+) B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo. Cancer Immunology and Immunotherapy. ISSN 0340-7004. 53(12), s. 1135–1145.
  • Dembic, Zlatko; Hofgaard, Peter Olaf; Omholt, Hilde & Bogen, Bjarne (2004). Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice. Scandinavian Journal of Immunology. ISSN 0300-9475. 60, s. 143–152.
  • Dellacasagrande, Jerome; Schreurs, Olav Joseph F; Hofgaard, Peter Olaf; Omholt, Hilde; Steinsvoll, Svein E B & Schenck, Karl [Vis alle 8 forfattere av denne artikkelen] (2003). Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scandinavian Journal of Immunology. ISSN 0300-9475. 57(6), s. 534–544.
  • Lundin, Knut E. A.; Hofgaard, Peter Olaf; Omholt, Hilde; Munthe, Ludvig Andre; Corthay, Alexandre & Bogen, Bjarne (2003). Therapeutic effect of anti-idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies. Blood. ISSN 0006-4971. 102, s. 605–612.
  • Lauritzsen, Grete Fossum; Hofgaard, Peter Olaf; Schenck, Karl & Bogen, Bjarne (1998). Clonal deletion as a tumor escape mechanism. International Journal of Cancer. ISSN 0020-7136. 78, s. 216–222.
  • Lauritzsen, Grete Fossum; Hofgaard, Peter Olaf; Schenck, Karl & Bogen, Bjarne (1998). Deletion of thymocytes specific for Ig idiotype produced by a tumor. International Journal of Cancer. ISSN 0020-7136. s. 216–222.

Se alle arbeider i Cristin

  • Haabeth, Ole Audun; Tveita, Anders; Fauskanger, Marte Hotvedt; Hennig, Kjartan; Hofgaard, Peter Olaf & Bogen, Bjarne (2016). Idiotype-specific CD4+ T cells eradicate disseminated myeloma. Leukemia. ISSN 0887-6924. 30(5), s. 1216–1220. doi: 10.1038/leu.2015.278.
  • Binsfeld, M.; Belle, L.; Hannon, M.; Hofgaard, Peter Olaf; Dubois, S & Otjacques, E. [Vis alle 10 forfattere av denne artikkelen] (2012). Adaptation of a murine chronic GvH model to study graft-versus-myeloma effect after allogeneic transplantation. Bone Marrow Transplantation. ISSN 0268-3369. 47, s. S184–S185.
  • Jodal, Henriette Cecilie; Hofgaard, Peter Olaf; Dembic, Zlatko & Bogen, Bjarne (2011). A New Mouse Model for Multiple Myeloma. Scandinavian Journal of Immunology. ISSN 0300-9475. 73(4), s. 388–388.
  • Lorvik, Kristina Berg; Corthay, Alexandre; Lundin, Katrin; Hofgaard, Peter Olaf; Omholt, Hilde & Bogen, Bjarne (2008). Role of antigen secretion for cancer immunosurveillance. Scandinavian Journal of Immunology. ISSN 0300-9475. 68, s. 217–218.
  • Corthay, Alexandre; Lorvik, Kristina Berg; Hofgaard, Peter Olaf; Omholt, Hilde & Bogen, Bjarne (2008). Transcriptomics of a successful antitumor immune response. Scandinavian Journal of Immunology. ISSN 0300-9475. 68, s. 209–209.
  • Lundin, Knut E. A.; Hofgaard, Peter Olaf; Omholt, Hilde & Bogen, Bjarne (2002). MHC Class II+B lymphomas: tumor-infiltrating dendritic cells are the primary stimulators of Idiotype (Id)-specific CD4+ T cells.
  • Lundin, Knut E. A.; Hofgaard, Peter Olaf; Omholt, Hilde; Corthay, Alexandre & Bogen, Bjarne (2002). Therapeutic effect of idiotype-specific CD4+ T cells against B cell lymphoma in the absence of anti-idiotypic antibodies.
  • Lundin, Knut E. A.; Hofgaard, Peter Olaf; Omholt, Hilde & Bogen, Bjarne (2001). MHC Class II+ B lymphomas: tumor-infiltrating dendritic cells are the primary stimulators of Idiotype (Id)-specific CD4+ T cells.
  • Ellingsen, Jan Eirik & Hofgaard, Peter Olaf (1990). A comparison of protein adsorption to TiO2 and to hydroxyapatite.

Se alle arbeider i Cristin

Publisert 13. apr. 2011 11:10 - Sist endret 7. sep. 2018 16:01